![Kristina Masson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristina Masson
Founder at
ACRIVON THERAPEUTICS, INC.
Net worth: 807 457 $ as of 2026-08-30
Profile
Kristina Masson is the founder of Acrivon Therapeutics, Inc., founded in 2018, and holds the title of Director & Executive VP-Business Operations since 2022.
Dr. Masson completed graduate and doctorate degrees at the University of Lund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-20 | 386,343 ( 0.9% ) | 807 457 $ | 2026-08-30 |
Kristina Masson active positions
| Companies | Position | Start |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Founder | 2018-02-28 |
Training of Kristina Masson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
- Stock Market
- Insiders
- Kristina Masson
